Search
×
×
Additional Filters
Added
Anytime
  • Anytime
  • Last 14-days
  • Last month
  • Last 3 months
  • Last 6 months
Price
No min
  • No min
  • 5,000
  • 10,000
  • 15,000
  • 20,000
  • 25,000
  • 30,000
  • 35,000
  • 40,000
  • 45,000
  • 50,000
  • 55,000
  • 60,000
  • 65,000
  • 70,000
  • 75,000
  • 80,000
  • 85,000
  • 90,000
  • 95,000
  • 100,000
  • 125,000
  • 150,000
  • 200,000
  • 250,000
  • 300,000
  • 350,000
  • 400,000
  • 450,000
  • 500,000
  • 550,000
  • 600,000
  • 650,000
  • 700,000
  • 750,000
  • 800,000
  • 900,000
  • 1,000,000
  • 1,500,000
  • 2,000,000
  • 3,000,000
No max
  • No max
  • 5,000
  • 10,000
  • 15,000
  • 20,000
  • 25,000
  • 30,000
  • 35,000
  • 40,000
  • 45,000
  • 50,000
  • 55,000
  • 60,000
  • 65,000
  • 70,000
  • 75,000
  • 80,000
  • 85,000
  • 90,000
  • 95,000
  • 100,000
  • 125,000
  • 150,000
  • 200,000
  • 250,000
  • 300,000
  • 350,000
  • 400,000
  • 450,000
  • 500,000
  • 550,000
  • 600,000
  • 650,000
  • 700,000
  • 750,000
  • 800,000
  • 900,000
  • 1,000,000
  • 1,500,000
  • 2,000,000
  • 3,000,000
Additional Filters
Back to listings Save

Behavioural science platform for clinical trial adherence in your area available for acquisition

Undisclosed

CONFIDENTIAL

  • Asking Price: Price on Application
  • Turnover: On request
  • Profit: On request

Business Details

Behavioural science platform designed to improve clinical trial adherence and retention accelerated

The opportunity

Opportunity to acquire a proven behavioural science platform business, combining proprietary resilience-based methodology with human-guided delivery.

 

Founded in 2020 and backed by public market investment, the business has developed a scalable technology platform that enables healthcare and pharma companies to improve clinical trial adherence and retention, increase returns on patient support programs and enhance treatment outcomes.

 

Rationale for sale

Restrictions on the availability of growth capital via the public markets means the business is looking for a new investor/partner to accelerate and scale the business.

 

Highlights

·         Across pharma and healthcare, non-adherence and clinical trial drop-off drive an estimated $16bn–$24bn in annual value loss, which the business is designed to address

·         The solution is operational and has now been commercialised through an initial launch with a Fortune 500 biotech, pharma, and MedTech customer

·         Active deployments in phase 2 and 3 clinical trials, including with global pharmaceutical and biotechnology companies

·         Achieved preferred vendor status with leading clinical research organisations

·         Content licensing agreement with a top-tier US pharmaceutical company

·         Library of 180 tailored behavioural tools targeting adherence and trial participation

·         US and Canadian Patents secured

·         The business is now seeking private investment to scale, building on prior funding of over $30m

 

Financial overview

·         Initial revenue of c.$500k following launch

·         Strong commercial pipeline across pharma and healthcare customers

·         Double digit growth forecast for FY26, with significant operating leverage as deployments scale

 

Interest & offers

·         Expressions of interest are sought for the purchase of this US business

·         Offers required by 12pm 24th April 2026

·         Interested parties will be requested to sign a non-disclosure agreement (NDA)

·         Potential purchaser will need to provide proof of funds and be able to transact in an accelerated timeframe

Read more

Contact Agent

Listing Statistics

Advert Statistics Graph

Contact the seller for more details, or book a viewing

Stay Safe

Do not pay any deposit to private sellers upfront. If you are looking to purchase a business, we advise that any deposits or transactions made are through a solicitor to prevent fraudulent activities from occuring.

Stay Safe

Do not share confidential information with any private sellers, including your home address, account passwords, bank accounts and credit card information.

Stay Safe

The vast majority of these scams involve the transfer of substantial sums of money. We advise all transactions made are through a solicitor to prevent fraudulent activities from occuring.

Stay Safe

Send a test amount before you consider handing over a large amount of funds. Maybe even try transferring £1, and then speaking to your solicitor to confirm receipt.

Stay Safe

Do not disclose proof of funds directly to the sellers. If the sellers request you to show proof of funds, we advise that it is done through a solicitor to prevent fraudulent activities from occuring.

Stay Safe

Buying a business is not covered by consumer rights legislation. It is your responsibility to acquire a business that holds up in quality and agreement.

Stay Safe

Fraudsters will typically use false news in an attempt to get you to act quickly. For example, 'Your account has been disabled. Reset your password now.'.

Stay Safe

Review the performance of a business to make appropriate financial projections. Some businesses are dormant or not trading, so it is essential to check their short and long-term potential.

Stay Safe

Legitimate emails from Rightbiz will be with the domain @rightbiz.co.uk. However, emails from [email protected], [email protected] or [email protected] are not affiliated with Rightbiz.

0 of 0

Contact seller

Loading...

Stay Safe

Do not pay any deposit to private sellers upfront. If you are looking to purchase a business, we advise that any deposits or transactions made are through a solicitor to prevent fraudulent activities from occuring.

Stay Safe

Don't share confidential information with any private sellers, including your home address, account passwords, bank accounts and credit card information.

Stay Safe

The vast majority of these scams involve the transfer of substantial sums of money. We advise all transactions made are through a solicitor to prevent fraudulent activities from occuring.

Stay Safe

Send a test amount before you consider handing over a large number of funds. Maybe even try transferring £1, and then speaking to your solicitor to confirm receipt.

Stay Safe

Do not disclose proof of funds directly to the sellers. If the sellers request you to show proof of funds, we advise that it is done through a solicitor to prevent fraudulent activities from occuring.

Stay Safe

Buying a business is not covered by consumer rights legislation. It is your responsibility to acquire a business that holds up in quality and agreement.

Stay Safe

Fraudsters will typically use false news in an attempt to get you to act quickly. For example, 'Your account has been disabled. Reset your password now.'.

Stay Safe

Review the performance of a business to make appropriate financial projections. Some businesses are dormant or not trading, so it is essential to check their short and long-term potential.

Stay Safe

Legitimate emails from Rightbiz will be with the domain @rightbiz.co.uk. However, emails from [email protected], [email protected] or [email protected] are not affiliated with Rightbiz.

0 of 0

Related Tags:

Recently viewed businesses

Disclaimer

The data showed regarding this advert 'Behavioural science platform designed to improve clinical trial adherence and retention accelerated - Project Vision / Rightbiz' comprises as a business advertisement. Rightbiz Ltd makes no warranty as to the accuracy or to the completeness of the advertisement or any linked or any associated information provided. In no event shall Rightbiz Ltd be liable for any damages or loss whatsoever including special, indirect, consequential, incidental or punitive damages for loss of profits and revenue, arising out of or connected with this website or to the use, reliance upon or performance of any information contained in or accessed from this website.